312 related articles for article (PubMed ID: 11257229)
21. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
22. CBF--a biophysical perspective.
Bushweller JH
Semin Cell Dev Biol; 2000 Oct; 11(5):377-82. PubMed ID: 11105902
[TBL] [Abstract][Full Text] [Related]
23. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.
Wang Q; Stacy T; Miller JD; Lewis AF; Gu TL; Huang X; Bushweller JH; Bories JC; Alt FW; Ryan G; Liu PP; Wynshaw-Boris A; Binder M; Marín-Padilla M; Sharpe AH; Speck NA
Cell; 1996 Nov; 87(4):697-708. PubMed ID: 8929538
[TBL] [Abstract][Full Text] [Related]
24. Crystallization and preliminary studies of the DNA-binding runt domain of AML1.
Bäckström S; Huang SH; Wolf-Watz M; Xie XQ; Härd T; Grundström T; Sauer UH
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):269-71. PubMed ID: 11173476
[TBL] [Abstract][Full Text] [Related]
25. Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromes.
Leroy H; Roumier C; Grardel-Duflos N; Macintyre E; Lepelley P; Fenaux P; Preudhomme C
Blood; 2002 May; 99(10):3848-50. PubMed ID: 11986246
[TBL] [Abstract][Full Text] [Related]
26. Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Takeuchi K; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Blood; 2000 Nov; 96(9):3154-60. PubMed ID: 11049997
[TBL] [Abstract][Full Text] [Related]
27. Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site.
Gutiérrez J; Sierra J; Medina R; Puchi M; Imschenetzky M; van Wijnen A; Lian J; Stein G; Stein J; Montecino M
Biochemistry; 2000 Nov; 39(44):13565-74. PubMed ID: 11063594
[TBL] [Abstract][Full Text] [Related]
28. DNA recognition by the RUNX1 transcription factor is mediated by an allosteric transition in the RUNT domain and by DNA bending.
Bartfeld D; Shimon L; Couture GC; Rabinovich D; Frolow F; Levanon D; Groner Y; Shakked Z
Structure; 2002 Oct; 10(10):1395-407. PubMed ID: 12377125
[TBL] [Abstract][Full Text] [Related]
29. The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains.
Berardi MJ; Sun C; Zehr M; Abildgaard F; Peng J; Speck NA; Bushweller JH
Structure; 1999 Oct; 7(10):1247-56. PubMed ID: 10545320
[TBL] [Abstract][Full Text] [Related]
30. Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome.
Imai O; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Leuk Lymphoma; 2002 Mar; 43(3):617-21. PubMed ID: 12002768
[TBL] [Abstract][Full Text] [Related]
31. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.
Li FQ; Person RE; Takemaru K; Williams K; Meade-White K; Ozsahin AH; Güngör T; Moon RT; Horwitz M
J Biol Chem; 2004 Jan; 279(4):2873-84. PubMed ID: 14594802
[TBL] [Abstract][Full Text] [Related]
32. Function of CBFbeta/Bro proteins.
Adya N; Castilla LH; Liu PP
Semin Cell Dev Biol; 2000 Oct; 11(5):361-8. PubMed ID: 11105900
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
34. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
[TBL] [Abstract][Full Text] [Related]
35. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
Kummalue T; Lou J; Friedman AD
Mol Cell Biol; 2002 Dec; 22(23):8278-91. PubMed ID: 12417730
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain.
Crute BE; Lewis AF; Wu Z; Bushweller JH; Speck NA
J Biol Chem; 1996 Oct; 271(42):26251-60. PubMed ID: 8824275
[TBL] [Abstract][Full Text] [Related]
37. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
Kurokawa M; Hirai H
Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
[TBL] [Abstract][Full Text] [Related]
38. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates.
Adya N; Stacy T; Speck NA; Liu PP
Mol Cell Biol; 1998 Dec; 18(12):7432-43. PubMed ID: 9819429
[TBL] [Abstract][Full Text] [Related]
39. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis.
Michaud J; Wu F; Osato M; Cottles GM; Yanagida M; Asou N; Shigesada K; Ito Y; Benson KF; Raskind WH; Rossier C; Antonarakis SE; Israels S; McNicol A; Weiss H; Horwitz M; Scott HS
Blood; 2002 Feb; 99(4):1364-72. PubMed ID: 11830488
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the human genomic structure of the Runt domain-encoding PEBP2/CBFalpha gene family.
Ahn MY; Bae SC; Maruyama M; Ito Y
Gene; 1996 Feb; 168(2):279-80. PubMed ID: 8654962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
